Please turn JavaScript on
CancerConnect icon

CancerConnect

Want to know the latest news and articles posted on CancerConnect?

Then subscribe to their feed now! You can receive their updates by email, via mobile or on your personal news page on this website.

See what they recently published below.

Website title: CancerConnect - By combining information with a social community CancerConnect provides cancer patients and their caregivers a unique destination to seek information, support, and inspiration.

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.29 / day

Message History

For many people treated for colorectal cancer, surgery is a major milestone. But even after all visible cancer has been removed, the question often remains whether every cancer cell has truly been eliminated.

Unfortunately, today’s imaging scans cannot always detect microscopic cancer cells that may still be hiding in the body. Because of this uncertainty, many pat...


Read full story

Every year, thousands of cancer researchers and doctors gather at the annual meeting of the American Society of Clinical Oncology (ASCO) to share the latest discoveries in cancer care. This year’s meeting brought encouraging news for people affected by breast cancer, with new research focused on personalized treatments, promising therapies, and improving quality of life.

...

Read full story

For many people, the end of cancer treatment doesn’t mean the end of the cancer experience. Even after chemotherapy, radiation, or surgery are finished, many survivors continue to struggle with anxiety, fatigue, emotional distress, and difficulty sleeping.

The good news? New research presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting s...


Read full story

Sacituzumab govitecan (Trodelvy) has been approved by the FDA as a new option for adults with advanced triple‑negative breast cancer (TNBC), both on its own and together with pembrolizumab (Keytruda), in the first‑line setting. This gives patients and oncologists a new, antibody‑drug conjugate–based backbone in a disease that has historically had very limited treatment choice...


Read full story